| Baldessarini
RJ, Hennen J, Wilson M, Calabrese J, Chengappa R, Keck Jr. PE,
McElroy SL, Sachs G, Vieta E, Welge JA, Yatham LN, Zarate Jr.
CA, Baker RW, Tohen M: Olanzapine vs. placedbo in acute mania:
Treatmet responses in subgroups. J Clin Psychopharmacology.
J Clin Psychopharmacology 2003;23(4): 370-76.
Bowden CL, Calabrese JR, Sachs G, Yatham LN,
Akthar-Asghar S, Hompland M, Montgomery P, Earl N, Smoot TM,
DeVeaugh-Geiss J for the Lamictal 606 Study Group: A placebo-controlled
18 month trial of lamotrigine and lithium maintenance treatment
in recently manic or hypomanic patients with bipolar I disorder.
Arch Gen Psychiatry. 2003 Apr;60(4):392-400.
Calabrese JR, Londborg P, Shelton MD, Shelton
MD: Citalopram treatment of fluoxetine intolerant depressed
patients. J Clin Psychiatry. 2003 May;64(5):562-567.
Calabrese JR, Hirschfeld RMA, Reed M, Davies
MA, Frye MA, Keck PE, Jr., Lewis L, McElroy SL, McNulty JP,
Wagner KD: Impact of bipolar disorder on a U.S. community sample.
J Clin Psychiatry. 2003 April;64(4):425-432.
Calabrese JR, Bowden CL, Sach G, Yatham L, Behnke
K, Mehtonen O-P, Montgomery P, Ascher J, Paska W, Earl NL, DeVeaugh-Geiss
J, for the Lamictal 605 Study Group: A placebo-controlled 18-month
trial of lamotrigine and lithium maintenance treatment in recently
depressed patients with bipolar I disorder. J Clin Psychiatry.
2003 Sept; 64(9):1013-1024.
Carlson GA, Jensen PS, Findling RL, Meyer RE,
Calabrese J, del Bello M, Emslie G, Flynn L, Goodwin F, Hellander
M, Kowatch R, Kusumakar V, Laughren T, Leibenluft E, McCracken
J, Nottelmann E, Pine D, Sachs G, Shaffer D, Simar R, Strober
M, Weller E, Wozniak J, Youngstrom E: Methodological issues
and controversies in clinical trials with child and adolescent
patients with bipolar disorder: Report of a Consensus Conference.
J Child & Adol. Psychopharmacology. J Child Adolesc Psychopharmacol.
2003 Spring;13(1):13-27.
Danielson CK, Youngstrom EA, Findling RL, Calabrese
JR: Discriminant validity of the General Behavior Inventory
Using Youth Report. J Abnorm Child Psychol. 2003 Feb;31(1):29-39.
Danielson CK, Feeny NC, Findling RL, Youngstrom
EA. Psychosocial treatment of bipolar disorders in adolescents:
a proposed cognitive-behavioral intervention. Cognitive and
Behavioral Practice. In Press.
Fergus EL, Miller RB, Luckenbaugh DA, Leverich
GS, Findling RL, Speer AM, Post RM. Is there progression from
irritability/dyscontrol to classic manic and depressive symptoms?
A retrospective community survey of parents of bipolar children.
Journal of Affective Disorders. 2003;77, 71-78.
Findling RL, McNamara NK, Gracious BL, Youngstrom
EA, Stansbrey RJ, Reed MD, Demeter CA, Branicky LA, Fisher KE,
Calabrese JR: Combination lithium and divalproex sodium in pediatric
bipolarity. J Am Acad Child Adolesc Psychiatry. 2003 Aug;42(8):895-901.
Findling RL, McNamara NK, Stansbrey RJ. Commentary
on “Possible ziprasidone-induced mania”. Journal
of the American Academy of Child and Adolescent Psychiatry.
2003;42:1012-1013.
Gracious BL, Findling RL, Seman C, Youngstrom
EA, Demeter CA, Calabrese JR. Elevated TSH in bipolar youth
prescribed both lithium and divalproex sodium. Journal of the
American Academy of Child and Adolescent Psychiatry. In Press.
Greenhill LL, Vitiello B, Riddle MA, Fisher
P, Shockey E, March JS, Levine J, Fried J, Abikoff H, Zito JM,
McCracken JT, Findling RL, Robinson J, Cooper TB, Davies M,
Varipatis E, Labellarte MJ, Scahill L, Walkup JT, Capasso L,
Rosengarten J. Review of safety assessment methods used in pediatric
psycho-pharmacology. J American Academy Child Adolescent Psychiatry.
2003;42, 627-633. In Press.
Greenhill LL, Vitiello B, Abikoff H, Levine
J, March JS, Riddle MA, Capasso L, Cooper TB, Davies M, Fisher
P, Findling RL, Fried J, Labellarte MJ, McCracken JT, McMahon
D, Robinson J, Skrobala A, Scahill L, Varipatis E, Walkup JT,
Zito JM. Developing methodologies for monitoring long-term safety
of psychotropic medications in children: report on the NIMH
Conference, September 25, 2000. Journal of the American Academy
of Child and Adolescent Psychiatry. 2003;42, 651-655.
Findling RL, McNamara NK, O’Riordan MA,
Reed MD, Demeter CA, Branicky LA, Blumer JL. An open-label pilot
study of St. John’s wort in juvenile depression. Journal
of the American Academy of Child and Adolescent Psychiatry.
2003;42, 908-914.
Findling RL. FDA-approved treatments for children
and adolescents with obsessive-compulsive disorder or major
depressive disorder. International Drug Therapy Newsletter.
2003;38:41-48.
Gyulai L, Bowden CL, McElroy SL, Calabrese JR,
Petty F, Swann AC, Chou JCY, Wassef A, Risch CS, Hirschfeld
RMA, Nemeroff C, Keck PE, Wozniak PJ: Maintenance efficacy of
divalproex in the prevention of bipolar depression. Neuropsychopharmacology.
2003 July; 28(7): 1377-85.
Hirschfeld RMA, Holzer C, Calabrese JR, Weissman
M, Reed M, Davies M, Frye MA, Keck P, McElroy S, Lewis L, Tierce
J, Wagner KD, Hazard E: Validity of the Mood Disorders Questionnaire:
A general population study. American Journal of Psychiatry.
2003 Jan;160(1):178-80.
Hirschfeld RMA, Calabrese JR, Weissman MM, Reed
M, Davies MA, Frye MA, Keck PE Jr., Lewis L, McElroy SL, McNulty
JP, Wagner KD: Screening for bipolar disorder in the community.
J Clin Psychiatry 2003;64-53-59.
Kahana SY, Youngstrom EA, Findling, RL, Calabrese
JR: Employing parent, teacher, and youth self-report checklists
in Identifying pediatric bipolar spectrum disorders: An examination
of diagnostic accuracy and clinical utility. J Child Adolescent
Psychopharmacology. 2003;13(4).
Martinez JM, Marangell LB, Ketter TA, Bowden
CL, Goldberg JF, Calabrese JR, Thase ME: Lamotrigine use in
patients with bipolar disorder: Baseline data from the STEP-BD
500. Bipolar Disorders. In Press.
Muzina D, Calabrese JR: Recent-placebo-controlled
acute trials of bipolar depression: Focus on methodology. Int
J Neuropsychopharmacol. 2003 Sep;6(3):285-91.
Muzina DJ, Calabrese JR: Maintenance therapies
in bipolar disorder: Focus on Randomized controlled trials.
Acta Scandinavica. December 2003. In Press.
Muzina D, Calabrese JR: Maintenance therapies
in bipolar disorder: Focus on randomized controlled trials.
Australian and New Zealand J Psychiatry. In Press.
Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz
D, Wisniewski SR, Lavori P, Lebowitz B, Rudorfer M, Frank E,
Nierenberg AA, Fava M, Bowden C, Ketter T, Marangell L, Calabrese
J, Kupfer D, Rosenbaum JF: Rationale, design, and methods of
the systematic enhancement program for bipolar disorder (STEP_BD).
Biol Psychiatry. 2003 Jun 1;53(11):1028-42.
Sajatovic M. Treatment for mood and anxiety
disorder: Quetiapine and Aripiprazole. Current Psychiatry Reports.
200;5(4):320-326.
Sajatovic M, Rosenthal M, Plax M, Meyers M,
Bingham C: Mental Illness and Menopause: A patient and family
perspective . Journal of Gender-Specific Medicine.2003; 6(2),
31-34.
Sajatovic M, Friedman-Hatters S, Saberwhal J,
Bingham CR. Clinical characteristics and hospital based resource
use among older adults with bipolar disorder, schizophrenia,
depression and dementia. Journal of Geriatric Psychiatry and
Neurology. In Press.
Sajatovic M. Bipolar Disorder in the Elderly:
Defining the role of the newer agents. Drugs and Aging. In Press.
Sajatovic M, Hrouda D, Davies M: Adherence enhancement
in bipolar disorder. Psychiatric Services. In Press.
Sanger TM, Tohen M, Vieta E, Dunner DL, Bowden
CL, Calabrese JR, Feldman PD, Jacobs TG, Breier A: Olanzapine
in the acute treatmnet of bipolar disorder with a history of
rapid cycling. J Affect Disord 2003 Jan;73(1-2):155-61.
Schneck CD, Miklowitz DJ, Calabrese JR, Allen
MH, Thomas MR, Wisniewski SR, Miyahara S, Shelton MD, Ketter
TA, Goldberg JF, Bowden CL, Sachs GS: Phenomenology of rapid
cycling bipolar disorder: Data from the first 500 participants
in the Systematic treatment enhancement program for bipolar
disorder. American J Psychiatry. In Press.
Swann AC, Daniel D, Kochan L, Wozniak P, Calabrese
JR: Psychosis in mania: Specificity of its role in severity
and treatment response. J Clin Psychiatry. In Press.
Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs
G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW,
Evans AR, Beymer K, Dube S, Tollefson GD, Breier A: Efficacy
of olanzapine and olanzapine-fluoxetine combination in the treatment
of bipolar depression. Arch Gen Psychiatry 2003 Nov;60(11):1079-88.
Tohen M, Chengappa KNR, Suppes T, Baker RW,
Zarate CA, Bowden CL, Sachs GS, Kupfer DJ, Ghaemi SN, Feldman
PD, Risser RC, Evants AR, Calabrese JR: Prevention of recurrence
of bipolar I disorder in patients responsive to treatment with
olanzapine combined with lithium or valproate: An 18-month comparison
of continued combination treatment versus lithium or valproate
monotherapy. Br J Psychiatry. In Press.
Toichi M, Findling RL, Kubota Y, Calabrese JR,
Wiznitzer M, McNamara NK, Yamamoto K. Hemodynamic differences
in the activation of the prefrontal cortex: Attention vs higher
cognitive processing. Neuropsychologia. In Press.
Treatment for Adolescents with Depression Study
(TADS) Team (including Robert Findling, MD and Norah Feeney),
PhD. Treatment for Adolescents with Depression Study (TADS):
Rationale, design and methods. Journal of the American Academy
of Child and Adolescent Psychiatry. 2003;42: 531-542.
Vitiello B, Riddle MA, Greenhill LL, March JS,
Levine J, Schachar RJ, Abikoff H, Zito JM, McCracken JT, Walkup
JT, Findling RL, Robinson J, Cooper TB, Davies M, Varipatis
E, Labellarte MJ, Scahill L, Capasso L. How can we improve the
assessment of safety in child and adolescent psychopharmacology?
Journal of the American Academy of Child and Adolescent Psychiatry.
2003;42, 634-641.
Wagner KD, Robb AS, Findling RL, Jin J, Gutierrez
M, Heydorn WE. A placebo-controlled trial of citalopram for
the treatment of major depression in children and adolescents.
American Journal of Psychiatry, In Press.
Wiznitzer M, Findling RL: Why do psychiatric
drug research in children? The Lancet. 2003;361, 1147-1148.
Yatham LN, Calabrese JR, Kusumakar V: Bipolar
depression: Criteria for treatment selection, definition of
refractoriness, and treatment options. Bipolar Disorders. 2003
Apr;5(2):85-97.
Youngstrom EA, Findling RL, Calabrese JR: Who
are the comorbid Adolescents? Agreement between psychiatric
diagnosis, youth, parent, and teacher report. J Abnorm Child
Psychol. 2003 Jun;31(3):231-45.
Youngstrom EA, Gracious BL, Danielson CK, Findling
RL, Calabrese JR: Toward an integration of parent and clinician
report on the Young Mania Rating Scale. J Affective Disorders.
2003;77:179-90.
Youngstrom EA, Findling RL, Calabrese JR, Gracious
BL, Demeter C, Delporto Bedoya D, Price M. Comparing diagnostic
accuracy of six potential screening instruments for bipolar
disorder in youths aged 5 to 17 years. Journal of the American
Academy of Child and Adolescent Psychiatry. In Press.
Post RM, Findling RL, Kahn RS: Interfaces between
seizures and affective disorders. Mount Sinai Journal of Medicine,
58, 310-323, 1991
Findling RL, Grcevich SJ, Lopez I, Schulz SC:
Antipsychotic medications in children and adolescents. Journal
of Clinical Psychiatry, 57[suppl 9], 19-23, 1996
Findling RL, Schulz SC, Reed MD, Blumer, JL:
The antipsychotics: a pediatric perspective. The Pediatric Clinics
of North America, 45, 1205-1232, 1998
Friedman L, Findling RL, Kenny JT, Swales T,
Stuve T, Jesberger JA, Lewin JS, Schulz SC: A magnetic resonance
imaging study of adolescent patients with either schizophrenia
or bipolar disorder as compared to healthy controls. Biological
Psychiatry, 46, 78-88, 1999
Dasari M, Friedman L, Jesberger J, Stuve TA,
Findling RL, Swales TP, Schulz SC: An MRI study of thalamic
size in adolescent patients with either schizophrenia or bipolar
disorder. Psychiatry Research, 91, 155-162, 1999
Findling RL, McNamara NK, Gracious BL: Paediatric
uses of atypical antipsychotics. Expert Opinion on Pharmacotherapy,
1, 935-945, 2000
Findling RL, Gracious BL, McNamara NK, Calabrese
JR: The rationale, design, and progress of two novel maintenance
treatment studies in pediatric bipolarity. Acta Neuropsychiatrica,
12, 136-138, 2000
Youngstrom EA, Findling RL, Danielson CK, Calabrese
JR. Discriminant validity of parent report of hypomanic and
depressive symptoms on the General Behavior Inventory. Psychological
Assessment, 13, 267-276, 2001
Findling RL. Paediatric psychopharmacology:
Closing the gaps between science and practice. Expert Opinion
on Pharmacotherapy, 2, 523-525, 2001
Gracious BL, Findling RL. Antipsychotic medications
for children and adolescents. Pediatric Annals, 30: 138-145,
2001
Findling RL, Gracious BL, McNamara NK, Youngstrom
EA, Demeter CA, Branicky LA, Calabrese JR. Rapid, continuous
cycling and psychiatric co-morbidity in pediatric bipolar I
disorder. Bipolar Disorders, 3: 202-210, 2001
Greenhill LL, Vitiello B, Abikoff H, Levine
J, March JS, Riddle MA, Capasso L, Cooper T, Davies M, Fisher
P, Findling RL, Fried J, Labellarte M, McCracken J, McMahon
D, Robinson J, Skrobala AM, Scahill L, Walkup J, Zito J. Improving
the methods for evaluating the safety of psychotropic medications
in children and adolescents. Current Therapeutic Research, 62:
873-884, 2001
Pillai JJ, Friedman L, Stuve TA, Trinidad S,
Jesberger JA, Lewin JS, Findling RL, Swales TP, Schulz SC. Increased
presence of white matter hyperintensities in adolescent patients
with bipolar disorder. Psychiatry Research: Neuroimaging, 114:
51-56, 2002
Findling RL, Youngstrom EA, Danielson CK, Delporto
D, Papish-David R, Townsend L, Calabrese JR. Clinical decision-making
using the General Behavior Inventory in juvenile bipolarity.
Bipolar Disorders, 4, 34-42, 2002 (translated into Spanish:
Toma de decisions clínicas con la utilización
del General Behavior Inventory en el trastorno bipolar infanto-juvenil.
Published in Bipolar Disorders (Ed Esp), 1, 29-37, 2003)
Youngstrom EA, Danielson CK, Findling RL, Gracious
BL, Calabrese JR: Factor structure of the Young Mania Rating
Scale for use with youths ages 5 to 17 years. Journal of Clinical
Child and Adolescent Psychology, 31, 567-572, 2002
Gracious BL, Youngstrom EA, Findling RL, Calabrese
JR. Discriminative validity of a parent version of the Young
Mania Rating Scale. Journal of the American Academy of Child
and Adolescent Psychiatry, 41, 1350-1359, 2002
Findling RL. Use of quetiapine in children and
adolescents. Journal of Clinical Psychiatry, 63 [suppl 13],
27-31, 2002
Kowatch RA, DelBello MP, Findling RL. Depressive
episodes in children and adolescents with bipolar disorders.
Clinical Neuroscience Research, 2, 158-160, 2002
Danielson CK, Youngstrom EA, Findling RL, Calabrese
JR. Discriminant validity of the General Behavior Inventory
using youth report. Journal of Abnormal Child Psychology, 31,
29-39, 2003
Carlson GA, Jensen PS, Findling RL, Meyer RE,
Calabrese J, DelBello MP, Emslie G, Flynn L, Goodwin F, Hellander
M, Kowatch R, Kusumakar V, Laughren T, Leibenluft E, McCracken
J, Nottelmann E, Pine D, Sachs G, Shaffer D, Simar R, Strober
M, Weller EB, Wozniak J, Youngstrom EA. Methodological issues
and controversies in clinical trials with child and Adolescent
patients with bipolar disorder: report of a consensus conference.
Journal of Child and Adolescent Psychopharmacology, 13, 1-15,
2003
Youngstrom EA, Findling RL, Calabrese JR. Who
are the comorbid adolescents? Agreement between psychiatric
diagnosis, youth, parent, and teacher report. Journal of Abnormal
Child Psychology, 31, 231-245, 2003
Greenhill LL, Vitiello B, Riddle MA, Fisher
P, Shockey E, March JS, Levine J, Fried J, Abikoff H, Zito JM,
McCracken JT, Findling RL, Robinson J, Cooper TB, Davies M,
Varipatis E, Labellarte MJ, Scahill L, Walkup JT, Capasso L,
Rosengarten J. Review of safety assessment methods used in pediatric
psycho-pharmacology. Journal of the American Academy of Child
and Adolescent Psychiatry, 42, 627-633, 2003
Vitiello B, Riddle MA, Greenhill LL, March JS,
Levine J, Schachar RJ, Abikoff H, Zito JM, McCracken JT, Walkup
JT, Findling RL, Robinson J, Cooper TB, Davies M, Varipatis
E, Labellarte MJ, Scahill L, Capasso L. How can we improve the
assessment of safety in child and adolescent psychopharmacology?
Journal of the American Academy of Child and Adolescent Psychiatry,
42, 634-641, 2003
Greenhill LL, Vitiello B, Abikoff H, Levine
J, March JS, Riddle MA, Capasso L, Cooper TB, Davies M, Fisher
P, Findling RL, Fried J, Labellarte MJ, McCracken JT, McMahon
D, Robinson J, Skrobala A, Scahill L, Varipatis E, Walkup JT,
Zito JM. Developing methodologies for monitoring long-term safety
of psychotropic medications in children: report on the NIMH
Conference, September 25, 2000. Journal of the American Academy
of Child and Adolescent Psychiatry, 42, 651-655, 2003
Findling RL, McNamara NK, Gracious BL, Youngstrom
EA, Stansbrey RJ, Reed MD, Demeter CA, Branicky LA, Fisher KE,
Calabrese JR. Combination lithium and divalproex in pediatric
bipolarity. Journal of the American Academy of Child and Adolescent
Psychiatry, 42, 895-901, 2003
Fergus EL, Miller RB, Luckenbaugh DA, Leverich
GS, Findling RL, Speer AM, Post RM. Is there progression from
irritability/dyscontrol to classic manic and depressive symptoms?
A retrospective community survey of parents of bipolar children.
Journal of Affective Disorders, 77, 71-78. 2003
Youngstrom EA, Gracious BL, Danielson CK, Findling
RL, Calabrese JR. Toward an integration of parent and clinician
report on the Young Mania Rating Scale. Journal of Affective
Disorders, 77, 179-190, 2003
Danielson CK, Feeny NC, Findling RL, Youngstrom
EA. Psychosocial treatment of bipolar disorders in adolescents:
a proposed cognitive-behavioral intervention. Cognitive and
Behavioral Practice, in press
Kahana SY, Youngstrom EA, Findling RL, Calabrese
JR. Employing parent, teacher, and youth self-report checklists
in identifying pediatric bipolar spectrum disorders: an examination
of diagnostic accuracy and clinical utility. Journal of Child
and Adolescent Psychopharmacology, in press
Toichi M, Findling RL, Kubota Y, Calabrese JR,
Wiznitzer M, McNamara NK, Yamamoto K. Hemodynamic differences
in the activation of the prefrontal cortex: Attention vs. higher
cognitive processing. Neuropsychologia, in press
Gracious BL, Findling RL, Seman C, Youngstrom
EA, Demeter CA, Calabrese JR. Elevated TSH in bipolar youth
prescribed both lithium and divalproex sodium. Journal of the
American Academy of Child and Adolescent Psychiatry, in press
Youngstrom EA, Findling RL, Calabrese JR, Gracious
BL, Demeter C, Delporto Bedoya D, Price M. Comparing diagnostic
accuracy of six potential screening instruments for bipolar
disorder in youths aged 5 to 17 years. Journal of the American
Academy of Child and Adolescent Psychiatry, in press
Toichi M, Findling RL, Youngstrom EA, Kubota
Y, McNamara NK, Shimizu M, Calabrese JR. Altered prefrontal
lobe function in juvenile bipolar disorder during manic episodes.
Submitted for peer review
Youngstrom EA, Findling RL, Calabrese JR. Effects
of adolescent manic symptoms on agreement between youth, parent,
and teacher ratings of behavior problems. Submitted for peer
review
Findling RL, McNamara NK, Youngstrom EA, Stansbrey
R, Gracious BL, Reed MD, Shelton M, Calabrese JR. A double blind
18-month trial of lithium versus divalproex maintenance treatment
in children and adolescents with bipolar disorder. Submitted
for peer review
Post R, Chang K, Findling RL, Geller B, Kowatch
R, Kutcher S, Leverich G. Editorial: Prepubertal bipolar disorder
I and NOS are separable from ADHD. Submitted for peer review.
Youngstrom EA, Findling RL, Calabrese JR. Towards
an evidence-based assessment of pediatric bipolar disorder.
Submitted for peer review.
Findling RL. Atypical antipsychotics in the
treatment of children and adolescents: introduction. Submitted
for peer review.
Findling RL, McNamara NK. Atypical antipsychotics
in the treatment of children and adolescents: clinical applications.
Submitted for peer review.
BOOKS/BOOK CHAPTERS
Findling RL, Kowatch RA, Post RM. Pediatric
Bipolar Disorder. Martin Dunitz Publishers, London, 2002
Findling RL (Editor). Scientific Proceedings
of the 49th Annual Meeting of the American Academy of Child
and Adolescent Psychiatry, American Academy of Child and Adolescent
Psychiatry, 2002
Findling RL, McNamara NK, Gracious BL. Antipsychotic
agents: traditional and atypical. In: Martin A., Scahill L,
Charney D, Leckman JF (eds.): Textbook of Child and Adolescent
Psychopharmacology. Oxford University Press, New York, 2003
Findling RL. Pediatric Use of Atypical Antipsychotic
Medications: Emerging Psychopharmacologic Options for the Developing
Child. Q.E.D. Communications, Hawthorne, NY, 2003
Feeny NC, Findling RL. Classification of psychiatric
disorders in childhood and adolescence. In: Soares JC and Gershon
S (eds): Handbook of Medical Psychiatry. Marcel Dekker, Inc.
, New York, 2003
Findling RL. The Role of Atypical Antipsychotics
in the Management of Selected Mental Disorders in Children and
Adolescents. Network for Continuing Medical Education, Secaucus,
NJ, 2003
Findling RL (Editor). Scientific Proceedings
of the 50th Annual Meeting of the American Academy of Child
and Adolescent Psychiatry, American Academy of Child and Adolescent
Psychiatry, 2003
Youngstrom EA, Findling RL, Feeny NC. Assessment
of bipolar spectrum disorders in children and adolescents. In
Psychosocial Approaches to Bipolar Disorder (Johnson SL, Leahy
RL, eds). New York, Guilford, 2003
Findling RL (ed). Use of Atypical Antipsychotics
in Children and Adolescents. Supplement to Journal of Clinical
Psychiatry. Submitted.
Book Reviews, Special Articles, & Letters:
Findling RL, Calabrese JR. Rapid cycling bipolar
disorder in children [letter]. The American Journal of Psychiatry,
157, 1526-1527, 2000
Findling RL. Making the difficult diagnosis
of bipolar disorder in the school-age child. Current Psychiatry,
1, 61, 2002
Wiznitzer M, Findling RL. Why do psychiatric
drug research in children? The Lancet, 361, 1147-1148, 2003
Findling RL, McNamara NK, Stansbrey RJ. Commentary
on “Possible ziprasidone-induced mania”. Journal
of the American Academy of Child and Adolescent Psychiatry 42:1012-1013,
2003 |
